The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,280.00
Bid: 6,300.00
Ask: 6,320.00
Change: -40.00 (-0.63%)
Spread: 20.00 (0.317%)
Open: 6,320.00
High: 6,430.00
Low: 6,280.00
Prev. Close: 6,320.00
FOUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

26 Jul 2023 15:23

RNS Number : 3051H
4imprint Group PLC
26 July 2023
 

26 July 2023

4imprint Group plc (the "Company")

 Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons.

 

The Company received notification on 26 July 2023 from each of Kevin Lyons-Tarr and David Seekings, Directors of the Company, that on 25 July 2023, they had received respectively 516 and 722 Ordinary Shares of 38 6/13 pence each in the Company ("Ordinary Shares"), pursuant to an exercise of save as you earn options under the 2021 Employee Stock Purchase Plan. The exercise price was $27.61 per share and both Kevin Lyons-Tarr and David Seekings have retained all such shares.

 As a result of the above, the total interests respectively of Kevin Lyons-Tarr and David Seekings in the Company are 266,425 and 187,501 shares, representing 0.95% and 0.67% of the Company's issued share capital.

 

Emma Taylor

Company Secretary

4imprint Group plc

Tel. +44 (0)20 3709 9680

Email: hq@4imprint.co.uk

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulations, provides further detail in respect of the transaction as described above. 

 1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Kevin Lyons-Tarr

2.

Reason for the notification

a.

Position/status

Chief Executive Officer

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

4imprint Group plc

b.

LEI

213800G95T751RN2CT94

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the Financial instrument, type of instrument:

Identification code:

Ordinary Shares of 38 6/13 pence

 

GB0006640972

b.

Nature of the transaction

Receipt of Ordinary Shares pursuant to an Exercise of Options under the 2021 Employee Stock Purchase Plan.

 

c.

Price(s) and volume(s)

516 shares at $27.61 per share

d.

Aggregated information

· Aggregated volume

· Price

 

n/a

 

e.

Date of the transaction

 25 July 2023

f.

Place of the transaction

Outside of a trading venue

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

David John Emmott Seekings

2.

Reason for the notification

a.

Position/status

Chief Financial Officer

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

4imprint Group plc

b.

LEI

213800G95T751RN2CT94

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the Financial instrument, type of instrument:

Identification code:

Ordinary Shares of 38 6/13 pence

 

GB0006640972

b.

Nature of the transaction

Receipt of Ordinary Shares pursuant to an Exercise of Options under the 2021 Employee Stock Purchase Plan.

 

c.

Price(s) and volume(s)

722 shares at $27.61 per share

d.

Aggregated information

· Aggregated volume

· Price

 

n/a

e.

Date of the transaction

 25 July 2023

f.

Place of the transaction

Outside of a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFFSDIIRFIV
Date   Source Headline
16th Apr 202410:23 amRNSAnnual Financial Report
3rd Apr 20243:42 pmRNSDirector/PDMR Shareholding
28th Mar 20241:58 pmRNSDirector/PDMR Shareholding
28th Mar 20249:05 amRNSEBT Purchase
13th Mar 20247:00 amRNSFinal Results
28th Feb 20248:33 amRNSHolding(s) in Company
13th Feb 20244:49 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSTrading Statement
8th Jan 20248:27 amRNSBlock listing Interim Review
13th Dec 20238:52 amRNSCommittee changes
4th Dec 20231:23 pmRNSHolding(s) in Company
14th Nov 202312:28 pmRNSEBT Purchase
7th Nov 20237:00 amRNSTrading Statement
9th Oct 20238:17 amRNSEBT Purchase
21st Sep 20238:15 amRNSHolding(s) in Company
18th Aug 20238:09 amRNSDirectorate Change
1st Aug 20238:47 amRNSTrading Statement
31st Jul 20239:20 amRNSTotal Voting Rights
26th Jul 20233:23 pmRNSDirector/PDMR Shareholding
4th Jul 20237:00 amRNSPension Buy-in Transaction
29th Jun 20239:06 amRNSAdditional Listing
27th Jun 20239:41 amRNSBlock listing Interim Review
6th Jun 20231:36 pmRNSEBT Purchase
24th May 20232:12 pmRNSResult of AGM
24th May 20237:00 amRNSAGM Statement
12th May 20234:01 pmRNSHolding(s) in Company
17th Apr 20235:30 pmRNSAnnual Financial Report
14th Apr 20232:53 pmRNSHolding(s) in Company
29th Mar 20238:38 amRNSDirector/PDMR Shareholding
28th Mar 20238:04 amRNSEBT Purchase
15th Mar 20237:00 amRNSFinal Results
20th Jan 20237:00 amRNSTrading Statement
7th Dec 20223:38 pmRNSEBT Purchase
4th Nov 20227:00 amRNSTrading Statement
27th Oct 202212:42 pmRNSDirector Declaration
10th Oct 20229:01 amRNSEBT Purchase
16th Sep 20221:49 pmRNSHolding(s) in Company
12th Sep 20229:21 amRNSHolding(s) in Company
10th Aug 20227:00 amRNSHalf-year Report
2nd Aug 20229:13 amRNSHolding(s) in Company
1st Aug 20228:39 amRNSHolding(s) in Company
1st Aug 20228:00 amEQSBloc Ventures: Demand for deep tech unhindered by downturn
19th Jul 20227:00 amRNSTrading Statement
7th Jul 20222:26 pmRNSHolding(s) in Company
24th Jun 20229:37 amRNSEBT Purchase
6th Jun 20229:25 amRNSEBT Purchase
24th May 20221:18 pmRNSResult of AGM
24th May 20227:00 amRNSAGM Statement and Notice of Results
17th May 20227:35 amRNSHolding(s) in Company
17th May 20227:34 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.